Evidence map›Paper›PMID 24575297›Full record

ArticleBrain sciences2013

Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.

Cherie M Southwood, Bozena Fykkolodziej, Fabien Dachet, Alexander Gow

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Neurogenetics of Pelizaeus-Merzbacher disease.Handbook of clinical neurology · 2018
    Review
  6. Fine-tuning PERK signaling for neuroprotection.Journal of neurochemistry · 2017
    Review
  7. Review
  8. Overexpression of CHOP in Myelinating Cells Does Not Confer a Significant Phenotype under Normal or Metabolic Stress Conditions.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Cherie M SouthwoodCenter for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Bozena FykkolodziejCenter for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Fabien DachetCenter for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, 48201, USA ; Dept of Neurology, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Alexander GowCenter for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, 48201, USA ; Dept of Neurology, Wayne State University School of Medicine, Detroit, MI, 48201, USA ; Carman and Ann Adams Dept of Pediatrics, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Wayne State University · US

Funding

Molecular Mechanisms of NeurodegenerationR01NS043783 · NINDS · WAYNE STATE UNIVERSITY · PI GOW, ALEXANDER · 2002 to 2010
$2.6M
Trb3-Mediated Modulation of Oligodendrocyte StressR56NS067157 · NINDS · WAYNE STATE UNIVERSITY · PI GOW, ALEXANDER · 2011 to 2011
$380k
NINDS NIH HHS R01 NS043783NINDS NIH HHS R56 NS067157
6 · The paper itself

Abstract

Although activation of the innate and adaptive arms of the immune system are undoubtedly involved in the pathophysiology of neurodegenerative diseases, it is unclear whether immune system activation is a primary or secondary event. Increasingly, published studies link primary metabolic stress to secondary inflammatory responses inside and outside of the nervous system. In this study, we show that the metabolic stress pathway known as the unfolded protein response (UPR) leads to secondary activation of the immune system. First, we observe innate immune system activation in autopsy specimens from Pelizaeus-Merzbacher disease (PMD) patients and mouse models stemming from PLP1 gene mutations. Second, missense mutations in mildly- and severely-affected Plp1-mutant mice exhibit immune-associated expression profiles with greater disease severity causing an increasingly proinflammatory environment. Third and unexpectedly, we find little evidence for dysregulated expression of major antioxidant pathways, suggesting that the unfolded protein and oxidative stress responses are separable. Together, these data show that UPR activation can precede innate and/or adaptive immune system activation and that neuroinflammation can be titrated by metabolic stress in oligodendrocytes. Whether-or-not such activation leads to autoimmune disease in humans is unclear, but the case report of steroid-mitigated symptoms in a PMD patient initially diagnosed with multiple sclerosis lends support.

Indexed as

chemokinescytokineslymphoidmicroarraysmyelin synthesis-deficientmyeloidrumpshaker

Identifiers

PMID24575297
PMCPMC3932547
OpenAlexW2169053480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.